What are the implications of the NICE Quality Standards?
The updated and expanded NICE quality standards should be used in all care settings to audit and improve services for people with chronic heart failure, according to Dr […]
The updated and expanded NICE quality standards should be used in all care settings to audit and improve services for people with chronic heart failure, according to Dr […]
Dr Rani Khatib is a consultant pharmacist in cardiology and cardiovascular research and associate professor at the University of Leeds. As a member of the NICE Guideline Development […]
Candy, sweet and salty snacks, sugary drinks, and ice cream brands frequently appear in videos posted by top child-influencers on “made-for-kids” YouTube channels, according to a new paper from researchers […]
The implementation of the two-tier soft drinks industry levy in the UK in 2018 was associated with an 8% reduction in obesity among 10-11 year old girls, with […]
A recent study provides preliminary evidence of the long-term relationship between prevention and control measures and influenza transmission in China during the COVID-19 pandemic, accounting for the impact […]
Transportation to and from cancer centers for outpatient cancer treatments has been identified as one of the two most impactful out-of-pocket costs that cancer patients and their families […]
The European Medicine Agency’s (EMA) key human medicines committee (CHMP) has recommended four medicines for approval at its November 2022 meeting. This brings to 84 the number of […]
Federal regulations ban tobacco companies from advertising to kids and prohibit profanity on television before 10 p.m. But what is protecting children from predatory advertising of junk food, […]
Current Food and Drug Administration (FDA) oversight of the vaping industry in the US is likely to have minimal impact, suggests an analysis of the regulator’s warning letters […]
The European Medicines Agency (EMA) has launched a pilot to support the translation of basic research developments into medicines that could make a difference in patients’ lives in […]
The European Medicines Agency (EMA) has approved 12 new medicines at the September meeting of its key decision-making panel, the Committee on Human Medicinal Products (CHMP). The expert […]
Recent media releases/statements on new prescription medicines (POMs) issued by the UK Department of Health and Social Care and its executive NHS agencies, risks flouting the strict regulations […]